Shixing Tang

Dr. Shixing Tang


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

24 March 2020 in medRxiv
Verified
Preprint
Open access
PDF file
PSPeng Shi
Peng Shi
YDYinqiao Dong
Yinqiao Dong
HYHuanchang Yan
Huanchang Yan
XLXiaoyang Li
Xiaoyang Li
CZChenkai Zhao
Chenkai Zhao
SXShuhua Xi
Shuhua Xi
OBJECTIVE: To investigate the impact of temperature and absolute humidity on the coronavirus disease 2019 (COVID-19) outbreak. DESIGN: Ecological study. SETTING: 31 provincial-level regions in mainland China. MAIN OUTCOME MEASURES: Data on COVID-19 incidence and climate between Jan 20 and Feb 29, 2020. RESULTS: The number of new confirm COVID-19 cases in mainland China peaked on Feb 1, 2020. COVID-19 daily incidence were lowest at -10 °C and highest at 10 °C, while the maximum incidence was observed at the absolute humidity of approximately 7 g/m 3 . COVID-19 incidence changed with temperature as daily incidence decreased when the temperature rose. No significant association between COVID-19 incidence and absolute humidity was observed in distributed lag nonlinear models. Additionally, A modified susceptible-exposed-infectious-recovered (M-SEIR) model confirmed that transmission rate decreased with the increase of temperature, leading to further decrease of infection rate and outbreak scale. CONCLUSION: Temperature is an environmental driver of the COVID-19 outbreak in China. Lower and higher temperatures might be positive to decrease the COVID-19 incidence. M-SEIR models help to better evaluate environmental and social impacts on COVID-19. What is already known on this topic: Many infectious diseases present an environmental pattern in their incidence. Environmental factors, such as climate and weather condition, could drive the space and time correlations of infectious diseases, including influenza. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be transmitted through aerosols, large droplets, or direct contact with secretions (or fomites) as influenza virus can. Little is known about environmental pattern in COVID-19 incidence. What this study adds: The significant association between COVID-19 daily incidence and temperature was confirmed, using 3 methods, based on the data on COVID-19 and weather from 31 provincial-level regions in mainland China. Environmental factors were considered on the basis of SEIR model, and a modified susceptible-exposed-infectious-recovered (M-SEIR) model was developed. Simulations of the COVID-19 outbreak in Wuhan presented similar effects of temperature on incidence as the incidence decrease with the increase of temperature.

5 March 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
DDDeming Duan
Deming Duan
KWKeke Wang
Keke Wang
CWCheng Wei
Cheng Wei
DFDudu Feng
Dudu Feng
YLYonghua Liu
Yonghua Liu
JGJimin Gao
Jimin Gao
Chimeric antigen receptor (CAR) technology has revolutionized cancer treatment, particularly in malignant hematological tumors. Currently, the BCMA-targeted second-generation CAR-T cells have showed impressive efficacy in the treatment of refractory/relapsed multiple myeloma (R/R MM), but up to 50% relapse remains to be addressed urgently. Here we constructed the BCMA-targeted fourth-generation CAR-T cells expressing IL-7 and CCL19 (i.e., BCMA-7 × 19 CAR-T cells), and demonstrated that BCMA-7 × 19 CAR-T cells exhibited superior expansion, differentiation, migration and cytotoxicity. Furthermore, we have been carrying out the first-in-human clinical trial for therapy of R/R MM by use of BCMA-7 × 19 CAR-T cells (ClinicalTrials.gov Identifier: NCT03778346), which preliminarily showed promising safety and efficacy in first two enrolled patients. The two patients achieved a CR and VGPR with Grade 1 cytokine release syndrome only 1 month after one dose of CAR-T cell infusion, and the responses lasted more than 12-month. Taken together, BCMA-7 × 19 CAR-T cells were safe and effective against refractory/relapsed multiple myeloma and thus warranted further clinical study.

22 December 2021 in Microbiology Spectrum
Verified
Journal Article
Open access
YLYuanhao Liang
Yuanhao Liang
HLHongqing Lin
Hongqing Lin
LZLirong Zou
Lirong Zou
JZJianhui Zhao
Jianhui Zhao
BLBaisheng Li
Baisheng Li
STShixing Tang
Shixing Tang
We described CRISPR-Cas12-based multiplex allele-specific assay for rapid SARS-CoV-2 variant genotyping. The new system has the potential to be quickly developed, continuously updated, and easily implemented for screening of SARS-CoV-2 variants in resource-limited settings. This approach can be adapted for emerging mutations and implemented in laboratories already conducting SARS-CoV-2 nucleic acid amplification tests using existing resources and extracted nucleic acid.

1 February 2022 in Annals of Internal Medicine
Verified
Journal Article
Open access
MKMin Kang
Min Kang
YYYao Yi
Yao Yi
YLYan Li
Yan Li
LSLimei Sun
Limei Sun
ADAiping Deng
Aiping Deng
JHJianfeng He
Jianfeng He
Real-world evidence on inactivated COVID-19 vaccines against the SARS-CoV-2 B.1.617.2 (Delta) variant is limited. The authors of this cohort study analyzed vaccination, surveillance, screening, tra... Visual Effectiveness of Inactivated COVID-19 Vaccines Against the Delta Variant. Real-world evidence on inactivated COVID-19 vaccines against the SARS-CoV-2 B.1.617.2 (Delta) variant is li... Background: Real-world evidence on inactivated COVID-19 vaccines against the highly transmissible B.1.617.2 (Delta) variant of SARS-CoV-2 is limited, leaving an important gap in the evidence base a...

17 February 2022 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
YLYuanhao Liang
Yuanhao Liang
HLHongqing Lin
Hongqing Lin
LZLirong Zou
Lirong Zou
XDXiaoling Deng
Xiaoling Deng
STShixing Tang
Shixing Tang